Jessica Arbogast
Family · Salt Lake City, UTNPI 1154721108
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 85.3% of it on its own, with 7 other manufacturers making up the rest. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $96.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$17K
- AbbVie$1K
- Alkermes, Inc.$559
- Braeburn Inc.$477
- Indivior Inc.$446
- Seagen Inc.$74
- plus $59 from 2 others
What the payments were for
- Consulting fees$2,04010%
- Speaking & faculty fees$7,35037%
- Travel & lodging$5,77229%
- Food & beverage$4,87324%
- Education$740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 84 | $17,160 |
| AbbVie | 65 | $1,334 |
| Alkermes, Inc. | 20 | $559 |
| Braeburn Inc. | 13 | $477 |
| Indivior Inc. | 22 | $446 |
| Seagen Inc. | 1 | $74 |
| Viiv Healthcare Company | 1 | $33 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,108 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $7,524 |
| Lurasidone Hcl | 12 | $999 |
| Bupropion XlBupropion Hcl | 18 | $500 |
| Mirtazapine | 11 | $373 |
| Duloxetine Hcl | 12 | $353 |
| Trazodone Hcl | 18 | $218 |
| Ibuprofen | 15 | $208 |
| Benztropine Mesylate | 13 | $170 |
| Clonidine Hcl | 12 | $146 |
| Sertraline Hcl | 20 | $142 |
| Topiramate | 13 | $104 |
| Fluticasone Propionate | 11 | $83 |
| Potassium Chloride | 11 | $72 |
| ValacyclovirValacyclovir Hcl | 13 | $67 |
| Lisinopril | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Other family in Salt Lake City
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Jennalyn MayeuxSalt Lake City$151K
- Kacie Doyle-DelgadoSalt Lake City$80K
- Melonie ThompsonSalt Lake City$45K
- Keisa LynchSalt Lake City$39K
- Christina CardonSalt Lake City$36K
- Jennifer LloydSalt Lake City$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.